Cargando…
Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus
OBJECTIVE: The progress of accelerated atherosclerosis in systemic lupus erythematosus (SLE) is incompletely understood. Circulating osteopontin (OPN) is increased in autoimmune conditions, e.g. SLE, and its serum concentration was recently reported to associate with subclinical atherosclerosis in S...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209759/ https://www.ncbi.nlm.nih.gov/pubmed/33957796 http://dx.doi.org/10.1177/09612033211013898 |
_version_ | 1783709193335734272 |
---|---|
author | Wirestam, Lina Saleh, Muna Svensson, Christina Compagno, Michele Zachrisson, Helene Wetterö, Jonas Sjöwall, Christopher |
author_facet | Wirestam, Lina Saleh, Muna Svensson, Christina Compagno, Michele Zachrisson, Helene Wetterö, Jonas Sjöwall, Christopher |
author_sort | Wirestam, Lina |
collection | PubMed |
description | OBJECTIVE: The progress of accelerated atherosclerosis in systemic lupus erythematosus (SLE) is incompletely understood. Circulating osteopontin (OPN) is increased in autoimmune conditions, e.g. SLE, and its serum concentration was recently reported to associate with subclinical atherosclerosis in SLE, as measured by carotid intima-media thickness. The aim of this study was to investigate whether OPN may be used as a surrogate biomarker of subclinical atherosclerosis in SLE patients with different disease phenotypes. METHODS: We recruited 60 well-characterised SLE cases and 60 age- and sex-matched healthy controls. The SLE cases were divided into three different disease phenotypes: SLE with antiphospholipid syndrome (APS), lupus nephritis, and isolated skin and joint involvement. Plasma OPN was detected by ELISA (Quantikine®, R&D Systems). Common carotid arteries intima media thickness was compared between the studied groups in relation to OPN levels and risk factors for vascular changes. Intima media thickness of common carotid arteries was measured by using a sensitive ultrasound technique (LOGIQ™ E9 ultrasound, GE Healthcare). RESULTS: OPN levels were significantly higher among the entire SLE group (n = 60) compared to the healthy controls (P = 0.03). SLE cases with concomitant APS (n = 20) showed higher OPN levels than the controls (P = 0.004), whereas none of the other two subgroups differed significantly from the healthy controls. OPN and intima media thickness were correlated to several traditional risk factors of atherosclerosis, as well as to SLE-related factors. Yet, no significant correlation was observed between OPN levels and ultrasound findings of the common carotid arteries. CONCLUSIONS: In line with previous studies, we observed increased OPN levels among SLE patients as compared to matched controls. However, the OPN concentrations did not correlate with intima media thickness of the common carotid arteries. Based on our findings, the use of OPN as a surrogate biomarker of subclinical atherosclerosis in SLE subjects, regardless of clinical phenotypes, cannot be recommended. |
format | Online Article Text |
id | pubmed-8209759 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-82097592021-06-28 Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus Wirestam, Lina Saleh, Muna Svensson, Christina Compagno, Michele Zachrisson, Helene Wetterö, Jonas Sjöwall, Christopher Lupus Papers OBJECTIVE: The progress of accelerated atherosclerosis in systemic lupus erythematosus (SLE) is incompletely understood. Circulating osteopontin (OPN) is increased in autoimmune conditions, e.g. SLE, and its serum concentration was recently reported to associate with subclinical atherosclerosis in SLE, as measured by carotid intima-media thickness. The aim of this study was to investigate whether OPN may be used as a surrogate biomarker of subclinical atherosclerosis in SLE patients with different disease phenotypes. METHODS: We recruited 60 well-characterised SLE cases and 60 age- and sex-matched healthy controls. The SLE cases were divided into three different disease phenotypes: SLE with antiphospholipid syndrome (APS), lupus nephritis, and isolated skin and joint involvement. Plasma OPN was detected by ELISA (Quantikine®, R&D Systems). Common carotid arteries intima media thickness was compared between the studied groups in relation to OPN levels and risk factors for vascular changes. Intima media thickness of common carotid arteries was measured by using a sensitive ultrasound technique (LOGIQ™ E9 ultrasound, GE Healthcare). RESULTS: OPN levels were significantly higher among the entire SLE group (n = 60) compared to the healthy controls (P = 0.03). SLE cases with concomitant APS (n = 20) showed higher OPN levels than the controls (P = 0.004), whereas none of the other two subgroups differed significantly from the healthy controls. OPN and intima media thickness were correlated to several traditional risk factors of atherosclerosis, as well as to SLE-related factors. Yet, no significant correlation was observed between OPN levels and ultrasound findings of the common carotid arteries. CONCLUSIONS: In line with previous studies, we observed increased OPN levels among SLE patients as compared to matched controls. However, the OPN concentrations did not correlate with intima media thickness of the common carotid arteries. Based on our findings, the use of OPN as a surrogate biomarker of subclinical atherosclerosis in SLE subjects, regardless of clinical phenotypes, cannot be recommended. SAGE Publications 2021-05-06 2021-07 /pmc/articles/PMC8209759/ /pubmed/33957796 http://dx.doi.org/10.1177/09612033211013898 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Papers Wirestam, Lina Saleh, Muna Svensson, Christina Compagno, Michele Zachrisson, Helene Wetterö, Jonas Sjöwall, Christopher Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus |
title | Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus |
title_full | Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus |
title_fullStr | Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus |
title_full_unstemmed | Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus |
title_short | Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus |
title_sort | plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus |
topic | Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209759/ https://www.ncbi.nlm.nih.gov/pubmed/33957796 http://dx.doi.org/10.1177/09612033211013898 |
work_keys_str_mv | AT wirestamlina plasmaosteopontinversusintimamediathicknessofthecommoncarotidarteriesinwellcharacterisedpatientswithsystemiclupuserythematosus AT salehmuna plasmaosteopontinversusintimamediathicknessofthecommoncarotidarteriesinwellcharacterisedpatientswithsystemiclupuserythematosus AT svenssonchristina plasmaosteopontinversusintimamediathicknessofthecommoncarotidarteriesinwellcharacterisedpatientswithsystemiclupuserythematosus AT compagnomichele plasmaosteopontinversusintimamediathicknessofthecommoncarotidarteriesinwellcharacterisedpatientswithsystemiclupuserythematosus AT zachrissonhelene plasmaosteopontinversusintimamediathicknessofthecommoncarotidarteriesinwellcharacterisedpatientswithsystemiclupuserythematosus AT wetterojonas plasmaosteopontinversusintimamediathicknessofthecommoncarotidarteriesinwellcharacterisedpatientswithsystemiclupuserythematosus AT sjowallchristopher plasmaosteopontinversusintimamediathicknessofthecommoncarotidarteriesinwellcharacterisedpatientswithsystemiclupuserythematosus |